» Articles » PMID: 9581564

The N-terminal Arg2, Arg3 and Arg4 of Human Lactoferrin Interact with Sulphated Molecules but Not with the Receptor Present on Jurkat Human Lymphoblastic T-cells

Overview
Journal Biochem J
Specialty Biochemistry
Date 1998 May 15
PMID 9581564
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

We previously characterized a 105 kDa receptor for human lactoferrin (hLf) on Jurkat human lymphoblastic T-cells. To delineate the role of the basic cluster Arg2-Arg3-Arg4-Arg5 of hLf in the interaction with Jurkat cells, we isolated N-terminally deleted hLf species of molecular mass 80 kDa lacking two, three or four N-terminal residues (hLf-2N, hLf-3N and hLf-4N) from native hLf that had been treated with trypsin. Native hLf bound to 102000 sites on Jurkat cells with a dissociation constant (Kd) of 70 nM. Consecutive removal of N-terminal arginine residues from hLf progressively increased the binding affinity but decreased the number of binding sites on the cells. A recombinant hLF mutant lacking the first five N-terminal residues (rhLf-5N) bound to 17000 sites with a Kd of 12 nM. The binding parameters of bovine lactoferrin (Lf) and native hLf did not significantly differ, whereas the binding parameters of murine Lf (8000 sites; Kd 30 nM) resembled those of rhLf-5N. Culture of Jurkat cells in the presence of chlorate, which inhibits sulphation, decreased the number of binding sites for both native hLf and hLf-3N but not for rhLf-5N, indicating that the hLf-binding sites include sulphated molecules. We propose that the interaction of hLf with a large number of binding sites (approx. 80000 per cell) on Jurkat cells is dependent on Arg2-Arg3-Arg4, but not on Arg5. Interaction with approx. 20000 binding sites per cell, presumably the hLf receptor, does not require the first N-terminal basic cluster of hLf. Moreover, the affinity of hLf for the latter binding site is enhanced approx. 6-fold after removal of the first basic cluster. Thus N-terminal proteolysis of hLf in vivo might serve to modulate the nature of its binding to cells and thereby its effects on cellular physiology.

Citing Articles

Lactoferrin: A Promising Therapeutic Molecule against Human Papillomavirus.

Kaplan M, Baktiroglu M, Kalkan A, Canbolat A, Lombardo M, Raposo A Nutrients. 2024; 16(18).

PMID: 39339673 PMC: 11435110. DOI: 10.3390/nu16183073.


Exploring the Role of Lactoferrin in Managing Allergic Airway Diseases among Children: Unrevealing a Potential Breakthrough.

Gori A, Brindisi G, Daglia M, Miraglia Del Giudice M, Dinardo G, Di Minno A Nutrients. 2024; 16(12).

PMID: 38931261 PMC: 11206375. DOI: 10.3390/nu16121906.


Lactoferrins in Their Interactions with Molecular Targets: A Structure-Based Overview.

Piacentini R, Boffi A, Milanetti E Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543184 PMC: 10974892. DOI: 10.3390/ph17030398.


Lactoferrin: from the structure to the functional orchestration of iron homeostasis.

Ianiro G, Rosa L, Bonaccorsi di Patti M, Valenti P, Musci G, Cutone A Biometals. 2022; 36(3):391-416.

PMID: 36214975 DOI: 10.1007/s10534-022-00453-x.


The Immunological Role of the Placenta in SARS-CoV-2 Infection-Viral Transmission, Immune Regulation, and Lactoferrin Activity.

Bukowska-Osko I, Popiel M, Kowalczyk P Int J Mol Sci. 2021; 22(11).

PMID: 34071527 PMC: 8198160. DOI: 10.3390/ijms22115799.


References
1.
Legrand D, Salmon V, Coddeville B, Benaissa M, Plancke Y, SPIK G . Structural determination of two N-linked glycans isolated from recombinant human lactoferrin expressed in BHK cells. FEBS Lett. 1995; 365(1):57-60. DOI: 10.1016/0014-5793(95)00441-b. View

2.
van Berkel P, Geerts M, van Veen H, Kooiman P, Pieper F, DE BOER H . Glycosylated and unglycosylated human lactoferrins both bind iron and show identical affinities towards human lysozyme and bacterial lipopolysaccharide, but differ in their susceptibilities towards tryptic proteolysis. Biochem J. 1995; 312 ( Pt 1):107-14. PMC: 1136233. DOI: 10.1042/bj3120107. View

3.
Roseanu A, Legrand D, Trif M, Salmon V, Motas C, Montreuil J . Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem J. 1995; 312 ( Pt 3):839-45. PMC: 1136191. DOI: 10.1042/bj3120839. View

4.
Miao H, Atzmon R, Peretz T, Vlodavsky I . Sulfate moieties in the subendothelial extracellular matrix are involved in basic fibroblast growth factor sequestration, dimerization, and stimulation of cell proliferation. J Biol Chem. 1996; 271(9):4879-86. DOI: 10.1074/jbc.271.9.4879. View

5.
Bi B, Liu J, Legrand D, Roche A, Capron M, SPIK G . Internalization of human lactoferrin by the Jurkat human lymphoblastic T-cell line. Eur J Cell Biol. 1996; 69(3):288-96. View